Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Alternative multi-agonists for obesity treatment GLP-1R/GcgR dual agonists have shown impressive metabolic benefits and inspired the search for what now represents a growing class of rationally designed multi-agonists with differentiated mechanisms of action for obesity therapy
Menopausal weight gain is not necessarily a result of women not being physically active or eating well
The people with a diagnosis of prediabetes if left unchecked risk developing Type 2
Mounjaro and Zepbound (generic name tirzepatide) are approved to treat several type 2 diabetes and weight loss, respectively
These ingredients support antioxidant beauty care, radiance and skin maintenance from within
In the matter of a few short decades, our lifestyles became much more sedentary and our diets shifted dramatically
US$ 24.72
US$ 27.53
US$ 21.42
US$ 24.01
US$ 27.66
US$ 29.62
US$ 27.69
